Alcohol Toxicity and Withdrawal

Full Review: Nov 2026 ByMashal Khan, MD, NewYork-Presbyterian Hospital | Abdo Semaan, MD, NYP Weill Cornell Medicine | Peer reviewed byMark Zimmerman, MD, South County Psychiatry
Last updated: Nov 2026
v1026581
View Patient Education

Alcohol (ethanol) is a central nervous system depressant. Large amounts consumed rapidly can cause respiratory depression, coma, and death. Large amounts chronically consumed damage the liver and many other organs. Alcohol withdrawal manifests as a continuum, ranging from tremors to seizures, hallucinations, and life-threatening autonomic instability in severe withdrawal (delirium tremens). Diagnosis is clinical or based on a diagnosis of typical complications (eg, alcohol-related liver disease).

Alcohol use is a problem in preteens and teenagers as well as adults. According to data from the U.S. National Institute on Alcohol Abuse and Alcoholism, in 2024 about half of people ≥ 12 years old reported having consumed alcohol in the past month (1). Among adults tracked in an earlier 2012–2013 study, approximately 16% were former drinkers, and 11% were lifetime abstainers (2). For most people who drink alcohol, the frequency and amount of consumption does not impair physical or mental health or the ability to safely carry out daily activities. However, acute alcohol intoxication is a significant factor in injuries, particularly those due to interpersonal violence, suicide, and motor vehicle crashes (3).

Chronic use and misuse of alcohol interferes with the ability to socialize and work. Although estimates vary across studies, the 2012–2013 study also reported that approximately 15% of adults in the United States met the criteria for an alcohol use disorder (AUD) (2). Binge drinking, defined as consuming ≥ 5 drinks per occasion for men and ≥ 4 drinks per occasion for women, is a particular problem among younger people (1).

General references

  1. 1. National Survey on Drug Use and Health (NSDUH). Key Substance Use and Mental Health Indicators in the United States: Results from the 2024 National Survey on Drug Use and Health. Publication Number PEP25-07-007, NSDUH Series H-60. Released July 2025.  Accessed May 27, 2027.

  2. 2. Grant BF, Goldstein RB, Saha T, et al. Epidemiology of DSM-5 alcohol use disorder results from the National Epidemiologic Survey on Alcohol and Related Conditions III. JAMA Psychiatry. 72 (8):757–766, 2015. doi: 10.1001/jamapsychiatry.2015.0584

  3. 3. Alpert HR, Slater ME, Yoon YH, Chen CM, Winstanley N, Esser MB. Alcohol Consumption and 15 Causes of Fatal Injuries: A Systematic Review and Meta-Analysis. Am J Prev Med. 2022;63(2):286-300. doi:10.1016/j.amepre.2022.03.025

Pathophysiology of Alcohol Toxicity and Withdrawal

One serving of alcohol (355-mL [12-oz] can of beer; 148-mL [5-oz] glass of wine; or 44-mL [1.5-oz] shot of distilled liquor) contains 10 to 15 g of ethanol. Alcohol is absorbed into the blood mainly from the small bowel, although some is absorbed from the stomach. Alcohol accumulates in the blood because absorption is more rapid than oxidation and elimination. The concentration peaks approximately 10 to 60 minutes after ingestion (1).

Less than 10% of ingested alcohol is excreted unchanged in urine, sweat, and expired air; the remainder is metabolized, mainly by the liver, where alcohol dehydrogenase converts ethanol to acetaldehyde (1). Acetaldehyde is ultimately oxidized to CO2 and water at a rate of 5 to 10 mL/hour (of ethanol); each milliliter yields approximately 7 kcal. Alcohol dehydrogenase in the gastric mucosa accounts for some metabolism; women have lower gastric alcohol dehydrogenase activity than men.

Alcohol exerts its effects by several mechanisms. Alcohol binds directly to GABA receptors in the central nervous system, causing sedation. Alcohol also directly affects cardiac, hepatic, and thyroid tissue.

Tolerance and dependence

Tolerance to alcohol develops rapidly; similar amounts cause less intoxication. Tolerance is caused by adaptational changes of central nervous system cells (cellular or pharmacodynamic tolerance) and by induction of metabolic enzymes. People who develop tolerance are less impaired than others at any given BAC and may reach a very high BAC. Some appear to function normally at a BAC of 300 to 400 mg/dL (65.1 to 86.8 mmol/L), a level that often causes unconsciousness in alcohol-naive people. However, ethanol tolerance is incomplete, and considerable intoxication and impairment occur with a large enough amount. Even people who have developed tolerance may die of respiratory depression secondary to alcohol overdose.

Alcohol-tolerant people are susceptible to alcoholic ketoacidosis, especially during binge drinking. Alcohol-tolerant people are cross-tolerant to many other central nervous system depressants (eg, barbiturates, nonbarbiturate sedatives, benzodiazepines).

The physical dependence accompanying tolerance is profound, and alcohol withdrawal has potentially fatal adverse effects.

Chronic effects

Chronic heavy alcohol intake typically leads to liver disorders (eg, fatty liver, alcoholic hepatitis, cirrhosis) (2); the amount and duration required vary (see Alcohol-Related Liver Disease). Patients with a severe liver disorder often have coagulopathy due to decreased hepatic synthesis of coagulation factors, increasing the risk of significant bleeding due to trauma (eg, from falls or vehicle crashes) and of gastrointestinal bleeding (eg, due to gastritis, from esophageal varices due to portal hypertension); people who misuse alcohol are at particular risk of gastrointestinal bleeding.

Chronic heavy intake also commonly causes the following (3):

Indirect long-term effects include undernutrition, particularly vitamin deficiencies.

Evidence does not support the concept of a cardioprotective or even safe level of alcohol consumption (4, 5). Thus, alcohol should not be recommended for this purpose, especially when there are several safer, more effective approaches to reduce cardiovascular risk.

Special populations

Young children who drink alcohol are at significant risk of hypoglycemia because alcohol impairs gluconeogenesis and their smaller stores of glycogen are rapidly depleted (6). Women may be more sensitive than men, even on a per-weight basis, because their gastric (first-pass) metabolism of alcohol is less due to lower activity of alcohol dehydrogenase in the gastric mucosa (7). Drinking alcohol during pregnancy may result in fetal alcohol spectrum disorders.

Pathophysiology references

  1. 1. Jones AW. Alcohol, its absorption, distribution, metabolism, and excretion in the body and pharmacokinetic calculations. WIREs Forensic Sci. 2019;1:e1340. https://doi.org/10.1002/wfs2.1340

  2. 2. Haber PS. Identification and Treatment of Alcohol Use Disorder. N Engl J Med. 2025;392(3):258-266. doi:10.1056/NEJMra2306511

  3. 3. National Institute on Alcohol Abuse and Alcoholism. Medical Complications: Common Alcohol-Related Concerns. Accessed May 28, 2026.

  4. 4. Millwood IY, Walters RG, Mei XW, et al. Conventional and genetic evidence on alcohol and vascular disease aetiology: a prospective study of 500 000 men and women in China. Lancet. 2019;393(10183):1831-1842. doi:10.1016/S0140-6736(18)31772-0

  5. 5. Wood A, Kaptoge S, Butterworth A et al. Risk thresholds for alcohol consumption: combined analysis of individual-participant data for 599 912 current drinkers in 83 prospective studies. Lancet. 2018;391:513-1523

  6. 6. Lamminpää A. Acute alcohol intoxication among children and adolescents. Eur J Pediatr. 1994;153(12):868-872. doi:10.1007/BF01954735

  7. 7. Frezza M, di Padova C, Pozzato G, Terpin M, Baraona E, Lieber CS. High blood alcohol levels in women. The role of decreased gastric alcohol dehydrogenase activity and first-pass metabolism. N Engl J Med. 1990;322(2):95-99. doi:10.1056/NEJM199001113220205. Erratum in: N Engl J Med. 1990 Aug 23;323(8):553. N Engl J Med. 1990 May 24;322(21):1540.

Symptoms and Signs of Alcohol Toxicity and Withdrawal

Acute effects

Symptoms progress proportionately to BAC. Actual levels required to cause given symptoms vary with tolerance, but the following stages have been defined (1):

  • Initial consumption (BAC 20 to 50 mg/dL [4.3 to 10.9 mmol/L]): Tranquility, mild sedation, and some decrease in fine motor coordination

  • Mild acute alcohol intoxication (BAC 50 to 100 mg/dL [10.9 to 21.7 mmol/L]): Euphoria/dysphoria, social disinhibition, impaired judgment, and a further decrease in coordination

  • Moderate acute alcohol intoxication (BAC 100 to 200 mg/dL [21.7 to 43.4 mmol/L]): Unsteady gait; prolonged reaction time; nystagmus, slurred speech, loss of behavioral inhibitions; memory, mood, and personality impairment

  • Severe acute alcohol intoxication (BAC 200 to 500 mg/dL [43.4 to 108.5 mmol/L]): Amnesia, diplopia, dysarthria, hypothermia, hypotension, nausea/vomiting, respiratory depression, coma

  • Life-threatening acute alcohol intoxication (BAC > 500 mg/dL [108.5 mmol/L]): Death

Emesis is common with moderate to severe intoxication; because emesis usually occurs with obtundation, aspiration is a significant risk (1).

In the United States, the legal definition of intoxication is a BAC of ≥ 0.08% (≥ 80 mg/dL, [17.4 mmol/L]) and varies by state; 0.08% is used most commonly.

Toxicity or overdose

In alcohol-naïve people, a BAC of 300 to 400 mg/dL (65.1 to 86.8 mmol/L) often causes unconsciousness, and a BAC ≥ 360 mg/dL (78.2 mmol/L) may be fatal (2). Sudden death due to respiratory depression or arrhythmias may occur, especially when large quantities are consumed rapidly. Other common effects include hypotension and hypoglycemia.

The effect of a particular BAC varies widely; symptoms in chronic alcohol users vary widely for a given BAC, and some chronic alcohol users seem unaffected and appear to function normally with a BAC in the 300-to-400 mg/dL (65.1-to-86.8 mmol/L) range, whereas others are significantly impaired at a BAC that is minimally symptomatic in chronic alcohol users (3, 4).

Chronic physical signs

Stigmata of chronic use include vascular spiders, and, in men, signs of hypogonadism and feminization (eg, smooth skin, lack of male-pattern baldness, gynecomastia, testicular atrophy). Undernutrition may lead to enlarged parotid glands.

Withdrawal

A continuum of symptoms and signs of central nervous system (including autonomic) hyperactivity may accompany cessation of alcohol intake (4, 5).

A mild alcohol withdrawal syndrome includes tremors, weakness, headache, sweating, hyperreflexia, and gastrointestinal symptoms, beginning 4 to 12 hours after alcohol use has stopped and BAC drops rapidly (4). Tachycardia may be present and blood pressure can be slightly elevated. Symptoms usually begin within about 6 hours of cessation. Some patients have generalized tonic-clonic seizures (called alcohol-related seizures or "rum fits") but usually not > 2 in short succession. Seizures can occur from 2 to 48 hours after cessation of alcohol (6).

Alcoholic hallucinosis (hallucinations without other impairment of consciousness) follows abrupt cessation from prolonged, excessive alcohol use, usually within 12 to 24 hours (6). Hallucinations are typically visual. Symptoms may also include auditory illusions and hallucinations that frequently are accusatory and threatening; patients are usually apprehensive and may be terrified by the hallucinations and by vivid, frightening dreams.

Alcoholic hallucinosis may resemble schizophrenia, although thought is usually not disordered and the history is not typical of schizophrenia. Symptoms do not resemble the delirious state of an acute organic brain syndrome as much as does delirium tremens (DT) or other pathologic reactions associated with withdrawal. Consciousness remains clear, and the signs of autonomic lability that occur in DT are usually absent. When hallucinosis occurs, it usually precedes DT and is transient.

Delirium tremens usually begins 48 to 72 hours after alcohol withdrawal (6); anxiety attacks, increasing confusion, poor sleep (with frightening dreams or nocturnal illusions), profuse sweating, and severe depression also occur. Fleeting hallucinations that arouse restlessness, fear, and even terror are common. Typical of the initial delirious, confused, and disoriented state is a return to a habitual activity; eg, patients frequently imagine that they are back at work and attempt to do some related activity.

Autonomic lability, evidenced by diaphoresis and increased pulse rate and temperature, accompanies the delirium and progresses with it. Mild delirium is usually accompanied by marked diaphoresis, a pulse rate of 100 to 120 beats/minute, and a temperature of 37.2 to 37.8° C. Marked delirium, with gross disorientation and cognitive disruption, is accompanied by significant restlessness, a pulse of > 120 beats/minute, and a temperature of > 37.8° C; risk of death is high (1 to 10%) (6, 7).

During delirium tremens, patients are suggestible to many sensory stimuli, particularly to objects seen in dim light. Vestibular disturbances may cause them to believe that the floor is moving, the walls are falling, or the room is rotating. As the delirium progresses, resting tremor of the hand develops, sometimes extending to the head and trunk. Ataxia is marked; care must be taken to prevent self-injury. Symptoms vary among patients but are usually the same for a particular patient with each recurrence.

Symptoms and signs references

  1. 1. Mirijello A, Sestito L, Antonelli M, Gasbarrini A, Addolorato G. Identification and management of acute alcohol intoxication. Eur J Intern Med. 2023;108:1-8. doi:10.1016/j.ejim.2022.08.013

  2. 2. Jones AW, Holmgren P. Comparison of blood-ethanol concentration in deaths attributed to acute alcohol poisoning and chronic alcoholism. J Forensic Sci. 2003;48(4):874-879.

  3. 3. Olson KN, Smith SW, Kloss JS, Ho JD, Apple FS. Relationship between blood alcohol concentration and observable symptoms of intoxication in patients presenting to an emergency department. Alcohol Alcohol. 2013;48(4):386-389. doi:10.1093/alcalc/agt042

  4. 4. American Psychiatric Association. Diagnostic and Statistical Manual of Mental Disorders. 5th ed, Text Revision. American Psychiatric Association Publishing; 2022.

  5. 5. Haber PS. Identification and Treatment of Alcohol Use Disorder. N Engl J Med. 2025;392(3):258-266. doi:10.1056/NEJMra2306511

  6. 6. Tiglao SM, Meisenheimer ES, Oh RC. Alcohol Withdrawal Syndrome: Outpatient Management. Am Fam Physician. 2021;104(3):253-262.

  7. 7. Schuckit MA. Recognition and management of withdrawal delirium (delirium tremens). N Engl J Med. 2014;371(22):2109-2113. doi:10.1056/NEJMra1407298

Diagnosis of Alcohol Toxicity and Withdrawal

  • History and physical examination

  • Acute intoxication: Sometimes BAC and a rapid blood glucose test

  • Chronic use: Complete blood count, magnesium, liver tests, and PT/PTT

  • Withdrawal: Evaluation to exclude central nervous system injury and infection

Diagnosis is usually made based on typical symptoms and signs. The Diagnostic and Statistical Manual of Mental Disorders, 5th edition,Text Revision (DSM-5-TR) defines alcohol intoxication as 1 of the following in conjunction with recent ingestion of alcohol and significant or problematic behavioral changes (1):

  • Slurring of speech

  • Lack of coordination

  • Gait disturbance

  • Nystagmus

  • Memory or attention impairment

  • Coma

In acute alcohol intoxication, laboratory tests are generally not helpful; diagnosis is usually made clinically. Exceptions include fingerstick glucose to exclude hypoglycemia and sometimes tests to determine BAC. Confirmation by breath or blood alcohol levels is useful for legal purposes (eg, to document intoxication in drivers or employees who appear impaired). BAC levels do not always correlate to the level of intoxication; for a given BAC level, chronic alcohol users may have less impairment compared to a person who does not drink regularly (1, 2). However, finding a low BAC in patients who have altered mental status is helpful because it expedites the search for an alternate cause.

Clinicians should not assume that a high BAC in patients with apparently minor trauma accounts for their obtundation, which may be due to intracranial injury or other abnormalities. Such patients should also have additional evaluation to search for evidence of trauma or toxicity due to other substances.

Chronic alcohol dependence is a clinical diagnosis; experimental markers of long-term use have not proved sufficiently sensitive or specific for general use. Screening tests such as AUDIT (Alcohol Use Disorders Identification Test) or the CAGE questionnaire can be used (3, 4). However, heavy alcohol users may have a number of metabolic derangements, so complete blood count, electrolytes (including magnesium), liver tests (including coagulation profile [PT/PTT]), serum ammonia, and serum albumin are often recommended.

The DSM-5-TR defines alcohol withdrawal as 2 or more of the following, hours to days after stopping or reducing heavy and/or prolonged alcohol use (1):

  • Diaphoresis or tachycardia (> 100 bpm)

  • Increase in hand tremor

  • Insomnia

  • Nausea/vomiting

  • Temporary hallucinations

  • Psychomotor agitation

  • Anxiety

  • Seizure (generalized tonic-clonic)

In severe withdrawal and toxicity, symptoms may resemble those of central nervous system injury or infection. Because concomitant medical and surgical conditions can occur simultaneously with alcohol withdrawal, medical evaluation with CT and lumbar puncture may be needed. Patients with mild symptoms do not require routine testing unless improvement is not marked within 2 to 3 days. An often-used clinical assessment tool for the severity of alcohol withdrawal is the Clinical Institute Withdrawal Assessment for Alcohol scale, revised (CIWA-Ar) (5).

Clinical Calculators
Clinical Calculators

For the diagnosis of withdrawal delirium (delirium tremens), the DSM-5-TR requires all of the following, clearly related to alcohol withdrawal (1):

  • Attention disturbance, developing over hours to days, representing a change from baseline

  • Additional disturbance in memory, orientation, language, visuospatial ability, or perception

  • Symptoms are not better explained by another medical condition or toxin exposure

Diagnosis references

  1. 1. American Psychiatric Association. Diagnostic and Statistical Manual of Mental Disorders. 5th ed, Text Revision. American Psychiatric Association Publishing; 2022.

  2. 2. Olson KN, Smith SW, Kloss JS, Ho JD, Apple FS. Relationship between blood alcohol concentration and observable symptoms of intoxication in patients presenting to an emergency department. Alcohol Alcohol. 2013;48(4):386-389. doi:10.1093/alcalc/agt042

  3. 3. Saunders JB, Aasland OG, Babor TF, de la Fuente JR, Grant M. Development of the Alcohol Use Disorders Identification Test (AUDIT): WHO Collaborative Project on Early Detection of Persons with Harmful Alcohol Consumption--II. Addiction. 1993;88(6):791-804. doi:10.1111/j.1360-0443.1993.tb02093.x

  4. 4. Ewing JA. Detecting alcoholism. The CAGE questionnaire. JAMA. 1984;252(14):1905-1907. doi:10.1001/jama.252.14.1905

  5. 5. Sullivan JT, Sykora K, Schneiderman J, Naranjo CA, Sellers EM. Assessment of alcohol withdrawal: the revised clinical institute withdrawal assessment for alcohol scale (CIWA-Ar). Br J Addict. 1989;84(11):1353-1357. doi:10.1111/j.1360-0443.1989.tb00737.x

Treatment of Alcohol Toxicity and Withdrawal

  • Airway support and aspiration prevention

  • Supportive measures

  • Fluid and electrolyte management

  • Often thiamine and folate

  • Sometimes antiemetics, sedatives, or anti-intoxicants

  • For withdrawal, benzodiazepines and sometimes also phenobarbital or propofol

Toxicity or overdose

Treatment of alcohol toxicity may include the following:

  • Airway protection

  • Sometimes IV fluids with thiamine, magnesium, and vitamins

The first priority is ensuring an adequate airway. For many patients, this involves placement in a lateral position to prevent aspiration of vomit (1); endotracheal intubation and mechanical ventilation are required for apnea or inadequate respirations. IV hydration is needed for hypotension or evidence of volume depletion but does not significantly enhance ethanol clearance. When IV fluids are used, a single dose of thiamine 100 mg IV is given to treat or prevent Wernicke encephalopathy (2); fluids often contain dextrose and folate (400 to 1000 mcg) as well (1). Many clinicians also add multivitamins and magnesium to the IV fluids.

Antiemetics can be used to prevent complications of vomiting, including esophageal tears (Boerhaave syndrome), variceal bleeding, and electrolyte derangements (1). Sedation, particularly with haloperidol, can be used for violent patients. Metadoxine is used to promote ethanol clearance but is not available in the United States.

Pearls & Pitfalls

  • Intravenous hydration does not significantly enhance ethanol clearance.

Disposition of the acutely intoxicated patient depends on clinical response, not a specific BAC.

Withdrawal

Mild to moderate withdrawal for those who are not at increased risk for complications may be treated in the outpatient setting. Appropriate patients are those without the following risk factors (3):

  • History of severe withdrawal, multiple withdrawal episodes, or withdrawal delirium

  • History of heavy alcohol use (>8 drinks/day)

  • History of multiple withdrawal episodes

  • Comorbid medical or psychiatric conditions

  • Age older than 65 years

  • Autonomic hyperactivity

  • Physiologic dependence on opioids or other drugs

  • Absence of social support or stable housing

  • Risk of harm to self or others

For those treated in the outpatient setting, nonpharmacologic supportive care may be appropriate in some subsets of very low risk patients (4).

Patients with severe alcohol withdrawal or delirium tremens should be managed in an intensive care unit until these symptoms abate. Treatment may include

  • IV thiamine to prevent Wernicke encephalopathy, often with folate

  • Benzodiazepines or phenobarbital to manage agitation and/or seizures

Thiamine 100 mg IV is given to prevent Wernicke encephalopathy (2). Folate 400 to 1000 mcg is usually given. Other vitamins and minerals are supplemented as needed.

Alcohol-tolerant people are cross-tolerant to some medications commonly used to treat withdrawal (eg, benzodiazepines).

Benzodiazepines are the mainstay of therapy. Dosage and route depend on the degree of agitation, vital signs, and mental status (3, 4). Diazepam, given 5 to 10 mg IV or orally hourly until sedation occurs, is a common initial intervention; lorazepam 1 to 2 mg IV or orally is an alternative. Chlordiazepoxide 50 to 100 mg orally every 4 to 6 hours, then tapered, is an older acceptable alternative for less severe cases of withdrawal. For patients with a significant liver disorder, a short-acting benzodiazepine (lorazepam) or one metabolized by glucuronidation (oxazepam) is preferred. (NOTE: Benzodiazepines may cause intoxication, physical dependence, and withdrawal in patients with alcohol use disorder and, therefore, should not be continued after the detoxification period.)

Phenobarbital 10 mg/kg (ideal body weight) IV may be used as an alternative, or in conjunction with benzodiazepines if benzodiazepines alone are ineffective, but respiratory depression is a risk with concomitant use, and physicians prescribing it should be experienced in its use (3, 5).

Carbamazepine , gabapentin, or valproic acid (when there is no liver disease or pregnancy) may also be used as an adjunct to benzodiazepines or when benzodiazepines are contraindicated (3). For severe hyperadrenergic activity or to reduce benzodiazepine requirements, short-term therapy (12 to 48 hours) with titrated beta-blockers (eg, metoprolol 25 to 50 mg orally or 5 mg IV every 4 to 6 hours), clonidine (0.1 to 0.2 mg IV every 2 to 4 hours), or dexmedetomidine can be used, but only as an adjunct and only if necessary. Antipsychotics (haloperidol, risperidone, quetiapine) are not recommended initially or as monotherapy because they may lower the seizure threshold, but they can be adjuncts for severe agitation or hallucinations (3).

A seizure, if brief and isolated, needs no specific therapy but should be followed by prophylaxis against another seizure, preferably with an IV benzodiazepine (3). Repeated or longer-lasting seizures should be treated. Routine use of phenytoin is unnecessary and unlikely to be effective in the absence of a underlying seizure disorder.

Delirium tremens may be fatal and thus must be treated promptly with high-dose IV benzodiazepines, preferably in an intensive care unit (3). Dosing is higher and more frequent than in mild withdrawal. Very high doses of benzodiazepines may be required, and there is no maximum dose or specific treatment regimen. Diazepam 5 to 10 mg IV or lorazepam 1 to 2 mg IV every 10 minutes is given as needed to control delirium; some patients require several hundred milligrams over the first few hours. Patients refractory to high-dose benzodiazepines may respond to phenobarbital; however, if phenobarbital is used after benzodiazepines, respiratory depression can be significant. As an alternative, phenobarbital may be used as the first agent (5).

Severe drug-resistant DT can be treated with a continuous infusion of lorazepam, diazepam, midazolam, propofol, or dexmedetomidine, usually with concomitant mechanical ventilation. Physical restraints should be avoided if possible to minimize additional agitation, but patients must not be allowed to escape, remove IVs, or otherwise endanger themselves. Intravascular volume must be maintained with IV fluids, and thiamine must be given promptly. Appreciably elevated temperature with DT is a poor prognostic sign, as is the need for physical restraints (6).

Treatment references

  1. 1. Mirijello A, Sestito L, Antonelli M, Gasbarrini A, Addolorato G. Identification and management of acute alcohol intoxication. Eur J Intern Med. 2023;108:1-8. doi:10.1016/j.ejim.2022.08.013

  2. 2. Smith H, McCoy M, Varughese K, Reinert JP. Thiamine Dosing for the Treatment of Alcohol-Induced Wernicke's Encephalopathy: A Review of the Literature. J Pharm Technol. 2021;37(2):107-113. doi:10.1177/8755122520962859

  3. 3. The ASAM Clinical Practice Guideline on Alcohol Withdrawal Management. J Addict Med. 2020;14(3S Suppl 1):1-72. doi:10.1097/ADM.0000000000000668. Erratum in: J Addict Med. 2020 Sep/Oct;14(5):e280. doi: 10.1097/ADM.0000000000000731

  4. 4. Tiglao SM, Meisenheimer ES, Oh RC. Alcohol Withdrawal Syndrome: Outpatient Management. Am Fam Physician. 2021;104(3):253-262.

  5. 5. Umar Z, Haseeb Ul Rasool M, Muhammad S, et al. Phenobarbital and Alcohol Withdrawal Syndrome: A Systematic Review and Meta-Analysis. Cureus. 2023;15(1):e33695. Published 2023 Jan 12. doi:10.7759/cureus.33695

  6. 6. Khan A, Levy P, DeHorn S, Miller W, Compton S. Predictors of mortality in patients with delirium tremens. Acad Emerg Med. 2008;15(8):788-790. doi:10.1111/j.1553-2712.2008.00187.x

Drug Information for the Topic

quizzes_lightbulb_red
Test your KnowledgeTake a Quiz!
IOS ANDROID
IOS ANDROID
iOS ANDROID